This is particularly important because the therapeutic approach to RA has greatly improved as a result of its earlier diagnosis and treatment [14, 15] and the availability of bio(techno)logical drugs such as anti-TNFα agents [16]. The gene discussed is TNF; the disease is rheumatoid arthritis.